Prime Medicine (PRME) Treasury Shares (2021 - 2022)

Prime Medicine (PRME) has 5 years of Treasury Shares data on file, last reported at $3.5 million in Q4 2025.

• Quarterly Treasury Shares changed 0.0% year-over-year to $3.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.5 million (changed 0.0% YoY) and the FY2025 annual result came in at $3.5 million, changed 0.0% from the prior year.
• Treasury Shares was little changed at $3.5 million in Q4 2025, from $3.5 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $161.4 million in Q3 2022 to a low of $573394.0 in Q1 2024.
• A 5-year average of $32.9 million and a median of $3.5 million in 2024 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2023 — Treasury Shares tumbled 99.22% — and 2025, when it jumped 505.61%.
• Tracing PRME's Treasury Shares over 5 years: stood at $45.7 million in 2021, then plunged by 91.61% to $3.8 million in 2022, then slumped by 76.43% to $903227.0 in 2023, then soared by 284.46% to $3.5 million in 2024, then changed by 0.0% to $3.5 million in 2025.
• The last three Treasury Shares figures came in at $3.5 million (Q4 2025), $3.5 million (Q3 2025), and $3.5 million (Q2 2025), per Business Quant data.